Muto MG - Search Results

1

Ovarian masses: can benign and malignant lesions be differentiated with color and pulsed Doppler US?

Brown DL, Frates MC, Laing FC, DiSalvo DN, Doubilet PM, Benson CB, Waitzkin ED, Muto MG. Brown DL, et al. Among authors: muto mg. Radiology. 1994 Feb;190(2):333-6. doi: 10.1148/radiology.190.2.8284377. Radiology. 1994. PMID: 8284377

2

Screening for ovarian cancer: the preliminary experience of a familial ovarian cancer center.

Muto MG, Cramer DW, Brown DL, Welch WR, Harlow BL, Xu H, Brucks JP, Tsao SW, Berkowitz RS. Muto MG, et al. Gynecol Oncol. 1993 Oct;51(1):12-20. doi: 10.1006/gyno.1993.1239. Gynecol Oncol. 1993. PMID: 8244166

3

Small echogenic foci in the ovaries: correlation with histologic findings.

Brown DL, Frates MC, Muto MG, Welch WR. Brown DL, et al. Among authors: muto mg. J Ultrasound Med. 2004 Feb;23(2):307-13. doi: 10.7863/jum.2004.23.2.307. J Ultrasound Med. 2004. PMID: 14992370

4

Unresorbed corpora albicantia mimicking a sonographically solid ovarian mass in a postmenopausal woman.

Brown DL, Hirsch MS, Muto MG, Laing FC. Brown DL, et al. Among authors: muto mg. J Ultrasound Med. 2004 Nov;23(11):1523-6. doi: 10.7863/jum.2004.23.11.1523. J Ultrasound Med. 2004. PMID: 15498920 No abstract available.

5

Sonographic predictors of ovarian malignancy.

Barroilhet L, Vitonis A, Shipp T, Muto M, Benacerraf B. Barroilhet L, et al. J Clin Ultrasound. 2013 Jun;41(5):269-74. doi: 10.1002/jcu.22014. Epub 2013 Mar 16. J Clin Ultrasound. 2013. PMID: 23504994

6

Differentiating leiomyosarcoma from leiomyoma: in support of an MR imaging predictive scoring system.

Jagannathan JP, Steiner A, Bay C, Eisenhauer E, Muto MG, George S, Fennessy FM. Jagannathan JP, et al. Among authors: muto mg. Abdom Radiol (NY). 2021 Oct;46(10):4927-4935. doi: 10.1007/s00261-021-03132-6. Epub 2021 Jun 1. Abdom Radiol (NY). 2021. PMID: 34075468

7

Preoperative serum CA-125 levels in borderline tumors of the ovary.

Rice LW, Lage JM, Berkowitz RS, Goodman A, Muto MG, Knapp RC, Bell DA. Rice LW, et al. Among authors: muto mg. Gynecol Oncol. 1992 Aug;46(2):226-9. doi: 10.1016/0090-8258(92)90260-p. Gynecol Oncol. 1992. PMID: 1500026

8

Monoclonal antibodies used in the detection and treatment of epithelial ovarian cancer.

Muto MG, Kassis AI. Muto MG, et al. Cancer. 1995 Nov 15;76(10 Suppl):2016-27. doi: 10.1002/1097-0142(19951115)76:10+<2016::aid-cncr2820761319>3.0.co;2-3. Cancer. 1995. PMID: 8634994 Review.

9

SPARC, an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells.

Mok SC, Chan WY, Wong KK, Muto MG, Berkowitz RS. Mok SC, et al. Among authors: muto mg. Oncogene. 1996 May 2;12(9):1895-901. Oncogene. 1996. PMID: 8649850

10

Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology.

Mok SC, Chao J, Skates S, Wong K, Yiu GK, Muto MG, Berkowitz RS, Cramer DW. Mok SC, et al. Among authors: muto mg. J Natl Cancer Inst. 2001 Oct 3;93(19):1458-64. doi: 10.1093/jnci/93.19.1458. J Natl Cancer Inst. 2001. PMID: 11584061

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

134 results

Search Page

Filters